Product NDC: | 53014-850 |
Proprietary Name: | Zaroxolyn |
Non Proprietary Name: | metolazone |
Active Ingredient(s): | 5 mg/1 & nbsp; metolazone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53014-850 |
Labeler Name: | UCB Manufacturing, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017386 |
Marketing Category: | NDA |
Start Marketing Date: | 19731127 |
Package NDC: | 53014-850-71 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (53014-850-71) |
NDC Code | 53014-850-71 |
Proprietary Name | Zaroxolyn |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (53014-850-71) |
Product NDC | 53014-850 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | metolazone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19731127 |
Marketing Category Name | NDA |
Labeler Name | UCB Manufacturing, Inc. |
Substance Name | METOLAZONE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide-like Diuretic [EPC] |